Synlogic, Inc. (SYBX)
OTCMKTS · Delayed Price · Currency is USD
0.71423
+0.01323 (1.89%)
At close: Jul 9, 2026
Synlogic Market Cap
Synlogic has a market cap or net worth of $8.35 million as of July 10, 2026. Its market cap has decreased by -37.89% in one year.
Market Cap
8.35M
Enterprise Value
-5.75M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.71
Market Cap Chart
Since August 28, 2017, Synlogic's market cap has decreased from 196.53M to 8.35M, a decrease of -95.75%. That is a compound annual growth rate of -29.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 8.35M | -36.24% |
| Dec 31, 2025 | 13.10M | -19.98% |
| Dec 31, 2024 | 16.37M | -53.72% |
| Dec 29, 2023 | 35.38M | -33.99% |
| Dec 30, 2022 | 53.60M | -68.23% |
| Dec 31, 2021 | 168.70M | 124.21% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Aug 28, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zeo ScientifiX | 13.85M |
| Inhibitor Therapeutics | 13.64M |
| Brainstorm Cell Therapeutics | 13.61M |
| LianBio | 11.96M |
| Adaptimmune Therapeutics | 9.54M |
| Biomind Labs | 8.53M |
| Reviva Pharmaceuticals Holdings | 7.87M |
| NKGen Biotech | 7.84M |